BioWorld

June 3, 2002

FDA Says Animal Studies Enough For Drugs To Counter Bioterrorism

WASHINGTON - A new FDA regulation allows drugs developed as antidotes to biological and chemical warfare to gain regulatory approval based on animal studies when human efficacy trials are not ethical. (BioWorld Today) Read More

Vion Stock Drops On News Of Staff Cuts, Realignment

Chip Analysis, Mouse-Mimicking Disease In Multiple Sclerosis May Reveal Possible Therapeutic Ploy

Proteome Sciences Paying £12.6M For Aventis' Proteomics Division

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for April 17, 2026.

Man holding raised arm with illustrated overlay of nerves

Biohaven reports details on discovery of BHV-2100

BioWorld Science

Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...

Elderly woman holding illustration of brain with missing puzzle piece

Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

BioWorld

The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...

News in brief

BioWorld Asia

BioWorld Asia briefs for April 14, 2026

Novel caspase-2 inhibitor shows in vivo neuroprotective effects

BioWorld Science

Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...